Public Health Partnering Terms and Agreements 2013 Report
Nov 05, 2013 (M2 PRESSWIRE via COMTEX) --
RnRMarketResearch.com adds Public Health Partnering Terms and Agreements - an on-demand research report to its store. This On Demand report is delivered in PDF format via email within 1-3 business days after ordering it. This research report provides a detailed understanding and analysis of how and why companies enter public health partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Complete report is available at http://www.rnrmarketresearch.com/public-health-partnering-terms-and-agreements-market-report.html .
This report provides details of the latest public health deals and contracts announced in the healthcare sectors. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not. The report includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. The initial chapters of this report provide an orientation of public health dealmaking and business activities. Bigpharma public health partnering company profiles are included in this report for Abbott, Actavis, Actelion, Allergan, Amgen, Astellas, AstraZeneca, Baxter International, Bayer, Bristol-Myers, Squibb C, Elgene, Eli Lilly, Endo Pharmaceuticals, Forest Laboratories, Galderma, GlaxoSmithKline, Hospira, Johnson & Johnson, Merck & Co, Merck KGaA, Mitsubishi Tanabe, Novartis, Pfizer, Roche, Sanofi, Shionogi, Shire, Teva, Warner Chilcott and Watson. Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=80647 .
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in public health dealmaking since 2007 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development.
Chapter 3 provides a review of the leading public health deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of public health deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
Chapter 5 provides comprehensive access to all public health deals since 2007 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of all public health partnering deals signed and announced since 2007. The chapter is organized by specific public health therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In addition, a comprehensive appendix is provided with each report of all public health partnering deals signed and announced since 2007. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in public health partnering and dealmaking since 2007.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of public health technologies and products.
Public Health Partnering Terms and Agreementsprovides the reader with the following key benefits:
- In-depth understanding of public health deal trends since 2007
- Access public health deal headline, upfront, milestone and royalty data
- Research hundreds of actual contracts between public health partner companies
- Comprehensive access to links to actual public health deals entered into by the world's biopharma companies
- Indepth review of public health deals entered into by the leading fifty bigpharma companies
- Benchmark the key deal terms companies have agreed in previous deals
- Identify key terms under which companies partner public health opportunities
- Uncover companies actively partnering public health opportunities
Public Health Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to public health trends and structure of deals entered into by leading companies worldwide.
Public Health Partnering Terms and Agreements includes:
o Trends in public health dealmaking in the biopharma industry since 2007
o Analysis of public health deal structure
o Access to headline, upfront, milestone and royalty data
o Access to hundreds of public health deal contract documents
o Comprehensive access to public health deal records
o The leading public health deals by value since 2007
o Most active public health dealmakers since 2007
In Public Health Partnering Terms and Agreements, available deals and contracts are listed by:
o Headline value
o Upfront payment value
o Royalty rate value
o Stage of development at signing
o Deal component type
o Technology type
o Specific therapy indication
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Comprehensive Table of Contents and more for this report is available at http://www.rnrmarketresearch.com/public-health-partnering-terms-and-agreements-market-report.html.
RnRMarketResearch.com is an online market research reports library of 350,000+ (http://www.rnrmarketresearch.com/latest_reports ) in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. Call +1 888 391 5441 with your research requirements.
CONTACT: Priyank Tiwari
+1 888 391 5441
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to firstname.lastname@example.org.
[ Back To Technology News's Homepage ]